Financial Market Analysis & Investment Research Partly open
AstraZeneca (AZN) – A change in stock exchange doesn't change the outlook, and +97.8%
AstraZeneca PLC is a British-Swedish biopharmaceutical company and one of the world leaders in oncology. The long-term corrective zigzag pattern is not yet complete, and the trend remains intact. The accuracy of the forecast is impressive.
Already subscribed to «Financial Market Analysis & Investment Research»? Then sign in to read it. Sign in
Full version
The closed part follows
The full material is available with the «Financial Market Analysis & Investment Research 42$» subscription, or as a single view.
- the full set of indicators and market factors;
- an interpretation of the current picture;
- conclusions and the signals that follow.
